Breast cancer

27 May 2010

Prenatal Exposure to Chemicals Linked to Breast Cancer Risk

BPA, DES affected offspring of pregnant mice, researchers found


This article has not necessarily been edited by Health24.

WEDNESDAY, May 26 (HealthDay News) -- The children of women who are exposed to certain industrial chemicals while pregnant are at an increased risk for developing breast cancer as adults, a new animal study suggests.

The chemicals -- bisphenol-A (BPA) and diethylstilbestrol (DES) -- are primarily produced for industrial manufacturing purposes, and are known for interfering with hormonal and metabolic processes, while disturbing neurological and immune function, among both people and animals.

"BPA is a weak estrogen and DES is a strong estrogen, yet our study shows both have a profound effect on gene expression in the mammary gland [breast] throughout life," study author Dr. Hugh Taylor, from the Yale University School of Medicine in New Haven, said in a news release from the Endocrine Society.

"All estrogens, even 'weak' ones, can alter the development of the breast and ultimately place adult women who were exposed to them prenatally at risk of breast cancer," he added.

The findings will be published in the June issue of Hormones & Cancer, the journal of the Endocrine Society.

The authors draw their conclusions from work with pregnant mice who were exposed to both BPA and DES. Once reaching adulthood, the offspring were found to produce higher than normal levels of a protein involved in gene regulation, called EZH2.

Above-normal EZH2 levels have previously been linked to a higher risk for breast cancer, the research team noted.

"We have demonstrated a novel mechanism by which endocrine-disrupting chemicals regulate developmental programming in the breast," said Taylor. "This study generates important safety concerns about exposures to environmental endocrine disruptors such as BPA and suggests a potential need to monitor women exposed to these chemicals for the development of breast lesions as adults."

More information

For more on breast cancer risk, visit the American Cancer Society.


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Breast cancer expert

Dr Gudgeon qualified in Birmingham, England, in 1968. She has more than 40 years experience in oncology, and in 1994 she founded her practice, Cape Breast Care, where she treats benign and malignant breast cancers. Dr Boeddinghaus obtained her qualification at UCT Medical School in 1994 and her MRCP in London in 1998. She has worked extensively in the field of oncology and has a special interest in the hormonal management of breast cancer. She now works with Dr Gudgeon at Cape Breast Care. Read more.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules